Dental Care Clinics in Carthage, NY Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Mccue Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3 Bridge St, Carthage, NY 13619 Phone: 315-493-3510 |
Carthage Area Hospital Inc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 3 Bridge St, Carthage, NY 13619 Phone: 315-493-3510 |
Long Falls Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 40 Franklin St Ste Iii, Carthage, NY 13619 Phone: 315-493-1581 |
Fondak Dental Offices, P.c. Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 33054 State Route 26, Carthage, NY 13619 Phone: 315-493-9393 Fax: 315-493-9394 |
Laclair Family Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 111 S Mechanic St, Carthage, NY 13619 Phone: 315-493-1184 Fax: 315-519-1545 |
A Happy Smile Dental Office, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 33054 State Route 26, Carthage, NY 13619 Phone: 315-493-9393 Fax: 315-493-9394 |
Carthage Dental Health Group, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 35426 State Route 126, Carthage, NY 13619 Phone: 315-493-2002 |
News Archive
Genome surveillance tool facilitates detection of COVID-19 variants
Swedish researchers have developed COVseq, a SARS-CoV-2 genome tracker that can be produced at a large scale for a small cost.
Empire State Building towers to go purple on 6th annual World Prematurity Day
The Empire State Building towers will light purple today in honor of the 6th annual World Prematurity Day (WPD) tomorrow. Parent groups and organizations worldwide join together on WPD to raise awareness of the serious problem of premature birth.
Variations in SORL1 gene may factor in development of Alzheimer's disease
Variations in a gene known as SORL1 may be a factor in the development of late onset Alzheimer's disease, an international team of researchers has discovered. The genetic clue, which could lead to a better understanding of one cause of Alzheimer's, is reported in Nature Genetics online, and was supported in part by the National Institutes of Health (NIH).
Pembrolizumab shows promising results in patients with classical Hodgkin Lymphoma
Merck, known as MSD outside of Canada and the United States, announced today early study findings demonstrating that patients treated with pembrolizumab, the company's investigational anti-PD-1 cancer therapy, achieved an overall response rate of 66 percent, as assessed by International Harmonization Project response criteria (n=19/29: 95% CI, 46-82).
Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema
Aerpio Therapeutics, a clinical-stage biopharmaceutical company developing innovative therapies for vascular diseases by targeting the Tie2 pathway, today announced that it has dosed the first patient in a Phase 1b/2a trial of AKB-9778 for the treatment of diabetic macular edema (DME).
› Verified 7 days ago